STRW · Strawberry Fields REIT, Inc.
Price & Indicators
Up next
AI Brief
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceBlended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders NeutralIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from written earnings releases and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| AFFO non-GAAP | 72.5M | the year ended December 31, 2025 | — |
| FFO non-GAAP | 79.6M | the year ended December 31, 2025 | — |
| FFO per share non-GAAP | $1.43 | the year ended December 31, 2025 | — |
Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period
Versus peers
REIT - Healthcare Facilities — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
STRW
this stock
Strawberry Fields REIT, Inc.
|
$193.53M | +4.1% | +32.4% | 21.4 | 1.3% |
|
WELL
Welltower Inc.
|
$167.58B | +27.9% | +35.6% | 118.1 | 2.5% |
|
VTR
Ventas, Inc.
|
$47.54B | +19.8% | +18.5% | 171.6 | 4.6% |
|
DOC
Healthpeak Properties, Inc.
|
$14.62B | +31.8% | +4.5% | 60.6 | 3.5% |
|
OHI
Omega Healthcare Investors Inc
|
$14.22B | +5.4% | +13.2% | 16.7 | 4.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| STRW | -0.4% | -3.2% | +6.6% | -4.1% | +4.1% |
| SPY | -2.0% | +3.3% | +11.2% | +2.1% | +11.8% |
| vs SPY | +1.5% | -6.5% | -4.6% | -6.2% | -7.7% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.